Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP) Advisor and FDA Advisory Committee Member Sarah Zenner-Dolan joins C-Path’s 20th Anniversary celebration to talk about her experience living with Parkinson’s, and how CPP is advancing drug development in Parkinson’s Disease.
